You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR DIATRIZOATE MEGLUMINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DIATRIZOATE MEGLUMINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03334578 ↗ The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients. Withdrawn Lawson Health Research Institute Phase 4 2018-08-03 This study will investigate the use of a drug called Gastrografin to aid in bowel mobility for paediatric patients who have undergone gastroschisis surgery. Gastroschisis is an abdominal wall birth defect where the bowel protrudes through a small opening beside the umbilicus. In these patients, the bowel is often less mobile due to its exposure outside of the body during fetal development. It is common for the bowel to be swollen and matted, which decreases motility and makes it increasingly difficult for the baby to have normal bowel function. Administering Gastrografin facilitates the entry of water into the intestines and bowel, which is thought to aid in bowel function and motility. This study will compare gastroschisis patients who received Gastrografin to gastroschisis patients collected as part of an ongoing observational study at our centre who did not receive Gastrografin.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DIATRIZOATE MEGLUMINE

Condition Name

Condition Name for DIATRIZOATE MEGLUMINE
Intervention Trials
Birth Defect 1
Bowel Obstruction 1
Gastroschisis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DIATRIZOATE MEGLUMINE
Intervention Trials
Intestinal Obstruction 1
Gastroschisis 1
Congenital Abnormalities 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DIATRIZOATE MEGLUMINE

Trials by Country

Trials by Country for DIATRIZOATE MEGLUMINE
Location Trials
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DIATRIZOATE MEGLUMINE

Clinical Trial Phase

Clinical Trial Phase for DIATRIZOATE MEGLUMINE
Clinical Trial Phase Trials
Phase 4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DIATRIZOATE MEGLUMINE
Clinical Trial Phase Trials
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DIATRIZOATE MEGLUMINE

Sponsor Name

Sponsor Name for DIATRIZOATE MEGLUMINE
Sponsor Trials
Lawson Health Research Institute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DIATRIZOATE MEGLUMINE
Sponsor Trials
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.